Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries. To further enhance the protective immune responses in populations that have completed vaccination...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jialu Zhang, Qian He, Chaoqiang An, Qunying Mao, Fan Gao, Lianlian Bian, Xing Wu, Qian Wang, Pei Liu, Lifang Song, Yaqian Huo, Siyuan Liu, Xujia Yan, Jinghuan Yang, Bopei Cui, Changgui Li, Junzhi Wang, Zhenglun Liang, Miao Xu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2021-01-01
coleção:	Emerging Microbes and Infections
Assuntos:	Heterologous prime-boost inactivated SARS-CoV-2 vaccine neutralizing antibody
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/22221751.2021.1957401
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!